Hyporesponsiveness and its clinical implications after vaccination with polysaccharide or glycoconjugate vaccines

Safety and Immunogenicity of a 13-Valent Pneumococcal Conjugate Vaccine Compared to Those of a 7-Valent Pneumococcal Conjugate Vaccine Given as a Three-Dose Series with Routine Vaccines in Healthy Infants and Toddlers

(2010) S. Esposito et al.   Clinical and Vaccine Immunology

Increased Risk of Hospitalization for Acute Lower Respiratory Tract Infection among Australian Indigenous Infants 5–23 Months of Age Following Pneumococcal Vaccination: A Cohort Study

(2010) Kerry‐Ann F. O’Grady et al.   CLINICAL INFECTIOUS DISEASES

Infants aged 12 months can mount adequate serotype-specific IgG responses to pneumococcal polysaccharide vaccine

(2010) Anne Balloch et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Nasopharyngeal Carriage ofStreptococcus pneumoniaeShortly before Vaccination with a Pneumococcal Conjugate Vaccine Causes Serotype‐Specific Hyporesponsiveness in Early Infancy

(2010) Ron Dagan et al.   JOURNAL OF INFECTIOUS DISEASES

Serotype-Specific Hyporesponsiveness to Pneumococcal Conjugate Vaccine in Infants Carrying Pneumococcus at the Time of Vaccination

(2010) Merja Väkeväinen et al.   JOURNAL OF PEDIATRICS

Safety and Immunogenicity of a 13-Valent Pneumococcal Conjugate Vaccine

(2010) K. A. Bryant et al.   PEDIATRICS

Safety and immunogenicity of the 23-valent pneumococcal polysaccharide vaccine at 12 months of age, following one, two, or three doses of the 7-valent pneumococcal conjugate vaccine in infancy

(2010) F.M. Russell et al.   VACCINE

Hyporesponsiveness to re-challenge dose following pneumococcal polysaccharide vaccine at 12 months of age, a randomized controlled trial

(2010) F.M. Russell et al.   VACCINE

Glycoconjugate vaccines and immune interference: A review

(2010) Ron Dagan et al.   VACCINE

Safety, tolerability, and immunologic noninferiority of a 13-valent pneumococcal conjugate vaccine compared to a 7-valent pneumococcal conjugate vaccine given with routine pediatric vaccinations in Germany

(2010) Dorothee M. Kieninger et al.   VACCINE

Opsonophagocytic activity following a reduced dose 7-valent pneumococcal conjugate vaccine infant primary series and 23-valent pneumococcal polysaccharide vaccine at 12 months of age

(2010) F.M. Russell et al.   VACCINE

Appearance of peripheral blood plasma cells and memory B cells in a primary and secondary immune response in humans

(2009) G. Blanchard-Rohner et al.   BLOOD

Evaluation of Pneumococcal Polysaccharide Immunoassays Using a 22F Adsorption Step with Serum Samples from Infants Vaccinated with Conjugate Vaccines

(2009) J. T. Poolman et al.   Clinical and Vaccine Immunology

Phase III Comparison of an Investigational Quadrivalent Meningococcal Conjugate Vaccine with the Licensed Meningococcal ACWY Conjugate Vaccine in Adolescents

(2009) Lisa A. Jackson et al.   CLINICAL INFECTIOUS DISEASES

Quadrivalent meningococcal ACYW-135 glycoconjugate vaccine for broader protection from infancy

(2009) David Pace   Expert Review of Vaccines

Plasma and memory B-cell kinetics in infants following a primary schedule of CRM197-conjugated serogroup C meningococcal polysaccharide vaccine

(2009) Dominic F. Kelly et al.   IMMUNOLOGY

Pneumococcal serotype 3 otitis media, limited effect of polysaccharide conjugate immunisation and strain characteristics

(2009) Jan Poolman et al.   VACCINE

Pneumococcal antibodies in a child with type 14 pneumococcal conjugate vaccine failure

(2009) Katherine L. O’Brien et al.   VACCINE

A dose-range study assessing immunogenicity and safety of one dose of a new candidate meningococcal serogroups A, C, W-135, Y tetanus toxoid conjugate (MenACWY-TT) vaccine administered in the second year of life and in young children

(2009) M. Knuf et al.   VACCINE

Meningococcal disease and prevention at the Hajj

(2009) Ray Borrow   Travel Medicine and Infectious Disease

Epidemiology and etiology of childhood pneumonia

(2008) Igor Rudan   BULLETIN OF THE WORLD HEALTH ORGANIZATION

Comparison of Pneumococcal Conjugate Polysaccharide and Free Polysaccharide Vaccines in Elderly Adults: Conjugate Vaccine Elicits Improved Antibacterial Immune Responses and Immunological Memory

(2008) Andrés de Roux et al.   CLINICAL INFECTIOUS DISEASES

Serotype-Specific Immune Unresponsiveness to Pneumococcal Conjugate Vaccine following Invasive Pneumococcal Disease

(2008) R. Borrow et al.   INFECTION AND IMMUNITY

Poor Immune Responses to a Birth Dose of Diphtheria, Tetanus, and Acellular Pertussis Vaccine

(2008) Natasha B. Halasa et al.   JOURNAL OF PEDIATRICS

Mechanisms in Neisseria meningitidis for resistance against complement-mediated killing

(2008) Elisabeth Kugelberg et al.   VACCINE